(Q39713274)

14 September 2017

1 reference

title

Development of antibacterial agents of the nalidixic acid type (English)

1 reference

14 September 2017

R. Albrecht

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A339272

29 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=339272

29 March 2023

publication date

1 January 1977

1 reference

full work available at URL

14 September 2017

http://link.springer.com/content/pdf/10.1007/978-3-0348-7098-6_1.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques

29 March 2023

published in

1 reference

14 September 2017

21

1 reference

14 September 2017

9-104

1 reference

Synthesis and antibacterial activity of some substituted 4-quinolone-3-carboxylic acids

14 September 2017

24

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Quinolone antibacterial agents. Oxolinic acid and related compounds

29 March 2023

28

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Investigations about the antibacterial activity of quinolonecarboxylic acids. II. Synthesis of I-ethyl-4-quinolone-3-carboxylic acids with fused five-membered heterocyclic rings

29 March 2023

30

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Synthetic chemotherapeutic agents. I. Synthesis of 2-substituted thiazolo(5,4-f)quinoline derivatives.(1)

29 March 2023

31

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Synthetic chemotherapeutic agents. II. Synthesis of 2-substituted thiazolo(5,4-f)quinoline derivatives

29 March 2023

32

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Synthetic chemotherapeutic agents. IV. Synthesis of 3-substituted thiazolo[5,4-f]quinoline derivatives

29 March 2023

33

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Synthetic chemotherapeutic agents. III. Synthesis of 3-substituted thiazolo(5,4-f)quinoline derivatives. (1)

29 March 2023

37

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Cytochrome c reduction by nalidixic and piromidic acids

29 March 2023

71

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Studies on Chemotherapeutic Agents. I. Syntheses of Quinoline and Naphthyridine Sulfonamide or Phosphonic Acid Derivatives

29 March 2023

102

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

In Vitro Susceptibility Comparisons and Recommendations for Oxolinic Acid

29 March 2023

116

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

The antibacterial and pharmacological activity of oxolinic acid (Prodoxol)

29 March 2023

118

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

In vitro investigations with oxolinic acid, a new chemotherapeutic agent.

29 March 2023

121

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Letter: Oxolinic acid in urinary infections.

29 March 2023

122

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria.

29 March 2023

123

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Letter: Antagonism of oxolinic acid by nitrofurantoin

29 March 2023

125

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Replication of Escherichia coli DNA in vitro: inhibition by oxolinic acid

29 March 2023

127

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Oxolinic acid, a new chemotherapeutic agent in the treatment of urinary tract infection

29 March 2023

131

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Pharrnacokinetics of nalidixinic acid and oxolinic acid in healthy wornen

29 March 2023

133

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Therapy of chronic urinary tract infections with oxolinic acid

29 March 2023

136

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Urinary tract infection treated with oxolinic acid

29 March 2023

138

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Oxolinic Acid in the Treatment of Typhoid Fever Due to Chloramphenicol-Resistant Strains of Salmonella typhi

29 March 2023

145

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Emergence of resistant organisms as a function of dose in oxolinic acid therapy

29 March 2023

147

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Biotransformation of the methylenedioxy moeity of oxolinic acid in man

29 March 2023

149

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Comparative Metabolism of Oxolinic Acid by the Rat, Rabbit and Dog

29 March 2023

150

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Bioevaluation of the antibacterial flumequine for urinary tract use

29 March 2023

152

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

In Vitro Evaluation of a New Quinolone Antibacterial

29 March 2023

153

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

The Synthesis of Certain Substituted Quinolines and 5,6-Benzoquinolines

29 March 2023

159

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

The synthesis of 4-hydroxyquinolines; through ethoxymethylene malonic ester.

29 March 2023

160

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

The reaction of diarylformamidines with ethyl malonate

29 March 2023

180

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Context control of search behavior: Evidence from a ‘Hurdling’-technique

29 March 2023

185

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Synthesis of 4-hydroxyquinolines; a direct synthesis of beta-substituted acrylic esters

29 March 2023

187

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Synthesis of 4-hydroxyquinolines; preparation through 3-cyano and 3-carbanilido derivatives

29 March 2023

191

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Compound 64716, a New Synthetic Antibacterial Agent

29 March 2023

204

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Cephaloridine therapy of infections caused by penicillin-resistant Staphylococcus aureus

29 March 2023

205

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

In Vitro Activity of Cinoxacin, an Organic Acid Antibacterial

29 March 2023

206

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Antibacterial Activity of Cinoxacin In Vitro

29 March 2023

207

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates

29 March 2023

208

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Cinoxacin: effectiveness against experimental pyelonephritis in rats

29 March 2023

209

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Efficacy of Cinoxacin in Urinary Tract Infections

29 March 2023

212

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

The preparation and purification of ethyl 6-ethyl-4-hydroxy [3-14C] cinnol-3-YL carboxylate (ICI 75,186)

29 March 2023

221

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents

29 March 2023

243

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Synthetic antibacterials. V. 7-Substituted 1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids

29 March 2023

246

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

ABSORPTION, EXCRETION, AND METABOLISM OF A NEW ANTIBACTERIAL AGENT, NALIDIXIC ACID

29 March 2023

254

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Studies on the Antibacterial Activity of 1-Substituted 1, 4-Dihydro-7-[2-(5-nitro-2-furyl) vinyl]-4-oxo-1, 8-naphthyridine Derivatives

29 March 2023

256

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Synthetic antibacterials. VI. 7-[1-Substituted 2-(5-nitro-2-furyl) vinyl]-1,8-naphthyridines

29 March 2023

257

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Synthesis of 2-methylpteridine derivatives

29 March 2023

260

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Time of onset of effective ventilation at birth

29 March 2023

262

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Synthesis of antimalarials; synthesis of certain 1,5- and 1,8-naphthyridine derivatives.

29 March 2023

289

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Cyclization of 2-aminopyridine derivatives; substituted ethyl 2-pyridylamino-methylenemalonates

29 March 2023

293

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Pyrido[2,3-d]pyrimidine antibacterial agents. I. 8-alkyl-5,8-dihydro-5-oxopyrido[2,3-d]-pyrimidine-6-carboxylic acids and related compounds.

29 March 2023

312

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Pyrido [2, 3-d] pyrimidine Antibacterial Agents. II. Piromidic Acid and Related Compounds

29 March 2023

314

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Metabolism in Rats and Man of Piromidic Acid, a New Antibacterial Agent

29 March 2023

316

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Synthetic antibacterials. 4. Nitrofurylvinylpyrido[2,3-d]pyrimidine derivatives

29 March 2023

325

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Metabolism of piromidic acid, a new antibacterial agent. III. Determination of piromidic acid and its metabolites in blood, urine and bile of rats and humans

29 March 2023

330

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Studies on chemotherapeutic agents. II. Synthesis and antibacterial activity of 5-substituted-5,8-dihydro-8-oxopyrido(2,3-b)-pyrazine-7-carboxylic acids

29 March 2023

336

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro properties

29 March 2023

342

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Metabolism of piromidic acid, a new antibacterial agent. IV. Pharmacokinetics of piromidic acid in rats

29 March 2023

345

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Metabolism of piromidic acid, a new antibacterial agent. II. In vitro metabolic pathway of piromidic acid in rats

29 March 2023

350

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Pipemidic Acid: Absorption, Distribution, and Excretion

29 March 2023

356

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Pipemidic Acid: Its Activities Against Various Experimental Infections

29 March 2023

361

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

Chemistry and pharmacology of a series of substituted 4H-pyrazino[1,2-a]pyrimidin-4-ones

29 March 2023

373

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7098-6_1

29 March 2023

Identifiers

0 references

1 reference